These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 8412619)
1. Effect of late administration of anti-TNF alpha antibodies on a Salmonella infection in the mouse model. Mastroeni P; Villarreal-Ramos B; Hormaeche CE Microb Pathog; 1993 Jun; 14(6):473-80. PubMed ID: 8412619 [TBL] [Abstract][Full Text] [Related]
2. Effect of interleukin 12 neutralization on host resistance and gamma interferon production in mouse typhoid. Mastroeni P; Harrison JA; Chabalgoity JA; Hormaeche CE Infect Immun; 1996 Jan; 64(1):189-96. PubMed ID: 8557339 [TBL] [Abstract][Full Text] [Related]
3. Serum TNF alpha in mouse typhoid and enhancement of a Salmonella infection by anti-TNF alpha antibodies. Mastroeni P; Arena A; Costa GB; Liberto MC; Bonina L; Hormaeche CE Microb Pathog; 1991 Jul; 11(1):33-8. PubMed ID: 1795626 [TBL] [Abstract][Full Text] [Related]
4. Role of T cells, TNF alpha and IFN gamma in recall of immunity to oral challenge with virulent salmonellae in mice vaccinated with live attenuated aro- Salmonella vaccines. Mastroeni P; Villarreal-Ramos B; Hormaeche CE Microb Pathog; 1992 Dec; 13(6):477-91. PubMed ID: 1363824 [TBL] [Abstract][Full Text] [Related]
5. The involvement of tumor necrosis factor in immunity to Salmonella infection. Tite JP; Dougan G; Chatfield SN J Immunol; 1991 Nov; 147(9):3161-4. PubMed ID: 1919009 [TBL] [Abstract][Full Text] [Related]
6. Adoptive transfer of immunity to oral challenge with virulent salmonellae in innately susceptible BALB/c mice requires both immune serum and T cells. Mastroeni P; Villarreal-Ramos B; Hormaeche CE Infect Immun; 1993 Sep; 61(9):3981-4. PubMed ID: 8359920 [TBL] [Abstract][Full Text] [Related]
7. Protection against oral challenge three months after i.v. immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen. Hormaeche CE; Mastroeni P; Harrison JA; Demarco de Hormaeche R; Svenson S; Stocker BA Vaccine; 1996 Mar; 14(4):251-9. PubMed ID: 8744548 [TBL] [Abstract][Full Text] [Related]
8. Gamma interferon and interleukin-10 gene expression in innately susceptible and resistant mice during the early phase of Salmonella typhimurium infection. Pie S; Matsiota-Bernard P; Truffa-Bachi P; Nauciel C Infect Immun; 1996 Mar; 64(3):849-54. PubMed ID: 8641791 [TBL] [Abstract][Full Text] [Related]
9. Mouse hepatitis virus strain UAB infection enhances resistance to Salmonella typhimurium in mice by inducing suppression of bacterial growth. Fallon MT; Benjamin WH; Schoeb TR; Briles DE Infect Immun; 1991 Mar; 59(3):852-6. PubMed ID: 1847697 [TBL] [Abstract][Full Text] [Related]
10. Serum TNF alpha inhibitor in mouse typhoid. Mastroeni P; Villarreal B; Demarco de Hormaeche R; Hormaeche CE Microb Pathog; 1992 May; 12(5):343-9. PubMed ID: 1501573 [TBL] [Abstract][Full Text] [Related]
11. Role of gamma interferon and tumor necrosis factor alpha in resistance to Salmonella typhimurium infection. Nauciel C; Espinasse-Maes F Infect Immun; 1992 Feb; 60(2):450-4. PubMed ID: 1730475 [TBL] [Abstract][Full Text] [Related]
12. Immunity conferred by Aro- Salmonella live vaccines. Hormaeche CE; Joysey HS; Desilva L; Izhar M; Stocker BA Microb Pathog; 1991 Feb; 10(2):149-58. PubMed ID: 1890952 [TBL] [Abstract][Full Text] [Related]
13. Effect of anti-tumor necrosis factor alpha antibodies on histopathology of primary Salmonella infections. Mastroeni P; Skepper JN; Hormaeche CE Infect Immun; 1995 Sep; 63(9):3674-82. PubMed ID: 7642306 [TBL] [Abstract][Full Text] [Related]
14. The full expression of the ity phenotype in ityr mice requires C3 activation by Salmonella lipopolysaccharide. Nishikawa F; Yoshikawa S; Harada H; Kita M; Kita E Immunology; 1998 Dec; 95(4):640-7. PubMed ID: 9893057 [TBL] [Abstract][Full Text] [Related]
15. Salmonella typhimurium strains carrying independent mutations display similar virulence phenotypes yet are controlled by distinct host defense mechanisms. Raupach B; Kurth N; Pfeffer K; Kaufmann SH J Immunol; 2003 Jun; 170(12):6133-40. PubMed ID: 12794143 [TBL] [Abstract][Full Text] [Related]
16. Genetic control of the innate resistance of mice to Salmonella typhimurium: expression of the Ity gene in peritoneal and splenic macrophages isolated in vitro. Lissner CR; Swanson RN; O'Brien AD J Immunol; 1983 Dec; 131(6):3006-13. PubMed ID: 6358358 [TBL] [Abstract][Full Text] [Related]
17. Moderate immunodeficiency does not increase susceptibility to Salmonella typhimurium aroA live vaccines in mice. Izhar M; DeSilva L; Joysey HS; Hormaeche CE Infect Immun; 1990 Jul; 58(7):2258-61. PubMed ID: 2194967 [TBL] [Abstract][Full Text] [Related]
18. Virulent Salmonella enterica infections can be exacerbated by concomitant infection of the host with a live attenuated S. enterica vaccine via Toll-like receptor 4-dependent interleukin-10 production with the involvement of both TRIF and MyD88. Foster GL; Barr TA; Grant AJ; McKinley TJ; Bryant CE; MacDonald A; Gray D; Yamamoto M; Akira S; Maskell DJ; Mastroeni P Immunology; 2008 Aug; 124(4):469-79. PubMed ID: 18217948 [TBL] [Abstract][Full Text] [Related]
19. Impaired resistance to infection does not increase the virulence of Salmonella htrA live vaccines for mice. Strahan K; Chatfield SN; Tite J; Dougan G; Hormaeche CE Microb Pathog; 1992 Apr; 12(4):311-7. PubMed ID: 1630300 [TBL] [Abstract][Full Text] [Related]
20. Immunity induced by live attenuated Salmonella vaccines. Hormaeche CE; Joysey HS; Desilva L; Izhar M; Stocker BA Res Microbiol; 1990; 141(7-8):757-64. PubMed ID: 2101466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]